Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway.

Hsu YL, Wu CY, Hung JY, Lin YS, Huang MS, Kuo PL.

Carcinogenesis. 2013 Jun;34(6):1370-81. doi: 10.1093/carcin/bgt040. Epub 2013 Feb 6.

PMID:
23389289
2.

Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor.

Kuo PL, Huang MS, Cheng DE, Hung JY, Yang CJ, Chou SH.

J Biol Chem. 2012 Mar 23;287(13):9753-64. doi: 10.1074/jbc.M111.321190. Epub 2012 Jan 30.

3.

S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer.

Hsu YL, Hung JY, Liang YY, Lin YS, Tsai MJ, Chou SH, Lu CY, Kuo PL.

Oncotarget. 2015 Oct 6;6(30):29585-98. doi: 10.18632/oncotarget.4987.

4.

Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion.

Kim TH, Kim HI, Soung YH, Shaw LA, Chung J.

Mol Cancer Res. 2009 Oct;7(10):1605-12. doi: 10.1158/1541-7786.MCR-09-0102. Epub 2009 Oct 6.

5.

Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.

Chung LY, Tang SJ, Sun GH, Chou TY, Yeh TS, Yu SL, Sun KH.

Clin Cancer Res. 2012 Aug 1;18(15):4037-47. Epub 2012 Jun 13.

6.

Lung tumor-associated dendritic cell-derived amphiregulin increased cancer progression.

Hsu YL, Huang MS, Cheng DE, Hung JY, Yang CJ, Chou SH, Kuo PL.

J Immunol. 2011 Aug 15;187(4):1733-44. doi: 10.4049/jimmunol.1100996. Epub 2011 Jul 8.

7.

Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.

Zhou X, Li D, Wang X, Zhang B, Zhu H, Zhao J.

Oncotarget. 2015 Feb 20;6(5):3111-22.

8.

The NOTCH ligand JAGGED2 promotes pancreatic cancer metastasis independent of NOTCH signaling activation.

Hu Y, Su H, Li X, Guo G, Cheng L, Qin R, Qing G, Liu H.

Mol Cancer Ther. 2015 Jan;14(1):289-97. doi: 10.1158/1535-7163.MCT-14-0501. Epub 2014 Oct 28.

9.

Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway.

Kuo PL, Hung JY, Huang SK, Chou SH, Cheng DE, Jong YJ, Hung CH, Yang CJ, Tsai YM, Hsu YL, Huang MS.

J Immunol. 2011 Feb 1;186(3):1521-30. doi: 10.4049/jimmunol.1002940. Epub 2010 Dec 29.

10.

Knockdown of Slit2 promotes growth and motility in gastric cancer cells via activation of AKT/β-catenin.

Shi R, Yang Z, Liu W, Liu B, Xu Z, Zhang Z.

Oncol Rep. 2014 Feb;31(2):812-8. doi: 10.3892/or.2013.2887. Epub 2013 Dec 2.

PMID:
24297051
11.

ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway.

Guo J, He L, Yuan P, Wang P, Lu Y, Tong F, Wang Y, Yin Y, Tian J, Sun J.

Oncol Rep. 2012 Nov;28(5):1709-18. doi: 10.3892/or.2012.2003. Epub 2012 Aug 30.

PMID:
22940701
12.

Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin.

Chen M, Sinha M, Luxon BA, Bresnick AR, O'Connor KL.

J Biol Chem. 2009 Jan 16;284(3):1484-94. doi: 10.1074/jbc.M803997200. Epub 2008 Nov 14.

13.

Detrimental effects of Notch1 signaling activated by cadmium in renal proximal tubular epithelial cells.

Fujiki K, Inamura H, Matsuoka M.

Cell Death Dis. 2014 Aug 14;5:e1378. doi: 10.1038/cddis.2014.339.

14.

A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis.

Chen CH, Thai P, Yoneda K, Adler KB, Yang PC, Wu R.

Oncogene. 2014 Jul 10;33(28):3696-706. doi: 10.1038/onc.2013.336. Epub 2013 Aug 19.

15.

Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways.

Wang Z, Li Y, Banerjee S, Kong D, Ahmad A, Nogueira V, Hay N, Sarkar FH.

J Cell Biochem. 2010 Mar 1;109(4):726-36. doi: 10.1002/jcb.22451. Erratum in: J Cell Biochem. 2016 Aug;117(8):1960.

PMID:
20052673
16.

Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression.

Hsu YL, Hung JY, Chou SH, Huang MS, Tsai MJ, Lin YS, Chiang SY, Ho YW, Wu CY, Kuo PL.

Oncogene. 2015 Jul 30;34(31):4056-68. doi: 10.1038/onc.2014.333. Epub 2014 Nov 10.

PMID:
25381822
17.

Notch1 controls cell invasion and metastasis in small cell lung carcinoma cell lines.

Hassan WA, Yoshida R, Kudoh S, Hasegawa K, Niimori-Kita K, Ito T.

Lung Cancer. 2014 Dec;86(3):304-10. doi: 10.1016/j.lungcan.2014.10.007. Epub 2014 Oct 22.

PMID:
25456735
18.

Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma.

Wang XQ, Zhang W, Lui EL, Zhu Y, Lu P, Yu X, Sun J, Yang S, Poon RT, Fan ST.

Int J Cancer. 2012 Aug 1;131(3):E163-72. doi: 10.1002/ijc.27336. Epub 2011 Dec 14.

19.

Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition.

Gupta SK, Oommen S, Aubry MC, Williams BP, Vlahakis NE.

Oncogene. 2013 Jan 10;32(2):141-50. doi: 10.1038/onc.2012.41. Epub 2012 Feb 27.

20.

Combination DLL4 with Jagged1-siRNA can enhance inhibition of the proliferation and invasiveness activity of human gastric carcinoma by Notch1/VEGF pathway.

Sun HW, Wu C, Tan HY, Wang QS.

Hepatogastroenterology. 2012 May;59(115):924-9. doi: 10.5754/hge11484.

PMID:
22020917

Supplemental Content

Support Center